Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomes

AIM: To assess whether the effects of sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors on cardiovascular, kidney and mortality outcomes are consistent with and without concomitant metformin use. MATERIAL AND METHODS: We conducted a meta‐analysis of event‐driven, randomized, placebo‐controlled SGLT...

Descripción completa

Detalles Bibliográficos
Autores principales: Neuen, Brendon L., Arnott, Clare, Perkovic, Vlado, Figtree, Gemma, de Zeeuw, Dick, Fulcher, Greg, Jun, Min, Jardine, Meg J., Zoungas, Sophia, Pollock, Carol, Mahaffey, Kenneth W., Neal, Bruce, Heerspink, Hiddo J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821162/
https://www.ncbi.nlm.nih.gov/pubmed/33043620
http://dx.doi.org/10.1111/dom.14226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821162/
https://www.ncbi.nlm.nih.gov/pubmed/33043620
http://dx.doi.org/10.1111/dom.14226

Ejemplares similares